MedTrace Logo

Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber

NCT04583202 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-06-09

No results posted yet for this study

Summary

The aim of this study is to assess the nasal and conjunctival response in subjects allergic to birch pollen during controlled exposures in the ALYATEC environmental exposure chamber (EEC)

Conditions

  • Allergic Rhinitis
  • Allergy to Pollen
  • Rhinoconjunctivitis

Interventions

OTHER

Exposure to placebo

Patients are exposed to a placebo for 4h in the Alyatec EEC

OTHER

Exposure to allergen

Patients are exposed to birch pollen allergens for 4h in the Alyatec EEC

Sponsors & Collaborators

  • Alyatec

    lead INDUSTRY

Principal Investigators

  • Frédéric de Blay, Pr. · Alyatec

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-24
Primary Completion
2020-10-19
Completion
2021-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04583202 on ClinicalTrials.gov